Literature DB >> 6162058

Distribution of albumin- and/or alpha-fetoprotein-positive cells in hepatocellular carcinoma.

M Kojiro, Y Kawano, T Isomura, T Nakashima.   

Abstract

Albumin (ALB)-positive cells were identified by an immunoperoxidase technique in 52 of 53 autopsy cases and in all of 13 surgical cases of hepatocellular carcinoma (HCC). The distribution pattern of ALB-positive cells could be classified into three groups: diffuse, localized, and sparse. The diffuse type was the most common pattern and was usually seen in well or moderately differentiated HCC, showing a trabecular growth pattern. The localized or sparse patterns were more frequent in poorly differentiated HCC showing a compact growth pattern. alpha-Fetoprotein (AFP)-positive cells were detected in 37 of the 53 autopsy cases of HCC and 11 of the 13 surgical cases. The number of AFP-positive cells and the intensity of the immunoperoxidase reaction were roughly proportional to serum AFP levels in most cases. In most regions of HCC, there seemed to be an inverse relationship between the number of ALB- and AFP-positive cells, suggesting tht most HCC cells synthesized only one of the two antigens studied. ALB-positive hepatocytes were found in all of the normal or cirrhotic livers examined and in the tumor-free regions of the HCC-containing livers. In contrast, AFP was not detected in nonneoplastic hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162058

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

1.  Ultrastructural observation of alpha-fetoprotein producing cells in human hepatocellular carcinoma using immunoperoxidase methods--comparison with fetal liver.

Authors:  S Kinoyama; G Yamada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-04

2.  Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.

Authors:  S Kinoyama; G Yamada; H Okushin; H Mimura; T Kobayashi; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1988-08

3.  Sigmoid colon metastasis from hepatocellular carcinoma.

Authors:  Dong Jun Yoo; Young Hwa Chung; Yoon Seon Lee; Sung Eun Kim; Young Joo Jin; Yu Mi Lee; Mi Jung Kim
Journal:  Korean J Hepatol       Date:  2010-12

4.  Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.

Authors:  Mohammad Shahid; Aysha Mubeen; Julie Tse; Sanjay Kakar; Adrian C Bateman; Darrell Borger; Miguel N Rivera; David T Ting; Vikram Deshpande
Journal:  Am J Surg Pathol       Date:  2015-01       Impact factor: 6.394

5.  DNA ploidy abnormalities in the liver of children with hereditary tyrosinemia type I. Correlation with histopathologic features.

Authors:  C Zerbini; D S Weinberg; K A Hollister; A R Perez-Atayde
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

6.  Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver.

Authors:  M A Gerber; S N Thung; S Shen; F W Stromeyer; K G Ishak
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

7.  In situ hybridisation of albumin mRNA in normal liver and hepatocellular carcinoma with a digoxigenin labelled oligonucleotide probe.

Authors:  G I Murray; P J Paterson; S W Ewen; W T Melvin
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

8.  Hepatocellular Carcinoma Metastasis to the Orbit in a Coinfected HIV+ HBV+ Patient Previously Treated with Orthotopic Liver Transplantation: A Case Report.

Authors:  S Guerriero; G Infante; E Giancipoli; S Cocchi; M G Fiore; D Piscitelli; N Cardascia
Journal:  Case Rep Ophthalmol Med       Date:  2011-12-20

9.  Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.

Authors:  C Haglund; J Lindgren; P J Roberts; S Nordling
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.